Onkure Therapeutics Inc (OKUR) USD0.0001

Sell:$3.32Buy:$4.66Price increased$0.13 (3.19%)

NASDAQ:Price increased0.19%
Market closed |
Prices delayed by at least 15 minutes
Sell:$3.32
Buy:$4.66
Change:Price increased$0.13 (3.19%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$3.32
Buy:$4.66
Change:Price increased$0.13 (3.19%)
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
23 March 2026
Jason A LeveroneCFO
Sell
Tax related
301$4.16$1,251.1116,000
23 March 2026
Nicholas A SaccomanoPresident/CEO
Sell
Tax related
86$4.16$357.467,333
22 December 2025
Jason A LeveroneCFO
Sell
Tax related
302$2.97$896.2516,301
22 December 2025
Nicholas A SaccomanoPresident/CEO
Sell
Tax related
87$2.97$258.197,419
22 September 2025
Jason A LeveroneCFO
Sell
Tax related
303$2.62$794.9212,603
22 September 2025
Nicholas A SaccomanoPresident/CEO
Sell
Tax related
88$2.62$230.873,506
23 June 2025
Jason A LeveroneCFO
Sell
Tax related
303$2.38$722.4112,906
23 June 2025
Nicholas A SaccomanoPresident/CEO
Sell
Tax related
88$2.38$209.813,594

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
23 March 2026
Jason A LeveroneCFO
Sell
Tax related
301$4.16$1,251.1116,000
22 December 2025
Jason A LeveroneCFO
Sell
Tax related
302$2.97$896.2516,301
22 September 2025
Jason A LeveroneCFO
Sell
Tax related
303$2.62$794.9212,603
23 June 2025
Jason A LeveroneCFO
Sell
Tax related
303$2.38$722.4112,906
23 March 2026
Nicholas A SaccomanoPresident/CEO
Sell
Tax related
86$4.16$357.467,333

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.